Mohammad Ali

ORCID: 0000-0003-0170-7182
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Head and Neck Anomalies
  • Immune Cell Function and Interaction
  • vaccines and immunoinformatics approaches
  • HIV Research and Treatment
  • Long-Term Effects of COVID-19
  • Hepatitis C virus research
  • Synthesis of heterocyclic compounds
  • COVID-19 Impact on Reproduction
  • Synthesis and Reactivity of Sulfur-Containing Compounds
  • Child Nutrition and Water Access
  • Head and Neck Cancer Studies
  • Hepatitis B Virus Studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Ear Surgery and Otitis Media
  • Head and Neck Surgical Oncology
  • Breastfeeding Practices and Influences
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Liver Disease Diagnosis and Treatment
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Synthesis and biological activity
  • Congenital Ear and Nasal Anomalies
  • Nasal Surgery and Airway Studies
  • HIV-related health complications and treatments

University of Oxford
2020-2025

Medawar Building for Pathogen Research
2020-2025

Nuffield Health
2024

Mahidol Oxford Tropical Medicine Research Unit
2023-2024

Mahidol University
2023-2024

Bangabandhu Sheikh Mujib Medical University
2009-2024

Directorate General of Health Services
2022-2024

Mawlana Bhashani Science and Technology University
2022

University of Maryland, College Park
2022

King Abdulaziz Hospital
2021

Rebecca P. Payne Stephanie Longet James Austin Donal Skelly Wanwisa Dejnirattisai and 95 more Sandra Adele Naomi Meardon Sian Faustini Saly Al‐Taei Shona C. Moore Tom Tipton Luisa M. Hering Adrienn Angyal Rebecca Brown Alexander R. Nicols Natalie Gillson Susan L. Dobson Ali Amini Piyada Supasa Andrew Cross Alice Bridges-Webb Laura Silva-Reyes Aline Linder Gurjinder Sandhar Jonathan A. Kilby Jessica K. Tyerman Thomas Altmann Hailey Hornsby Rachel Whitham Eloise Phillips Tom Malone Alexander Hargreaves Adrian M. Shields Ayoub Saei Sarah Foulkes Lizzie Stafford Síle A. Johnson Dan Wootton Christopher P. Conlon Katie Jeffery Philippa C. Matthews John Frater Alexandra Deeks Andrew J. Pollard Anthony Brown Sarah Rowland–Jones Juthathip Mongkolsapaya Eleanor Barnes Susan Hopkins Victoria Hall Christina Dold C.J. Duncan Alex Richter Miles W. Carroll Gavin Screaton Thushan I. de Silva Lance Turtle Paul Klenerman Susanna Dunachie Hibatullah Abuelgasim Emily Adland Syed Adlou Hossain Delowar Akther Ahmed Alhussni Mohammad Ali M. Azim Ansari Carolina V. Arancibia-Cárcamo Martin Bayley Helen Brown Jeremy Chalk Meera Chand Anu Chawla Senthil Chinnakannan Joseph Cutteridge Catherine de Lara Lucy Denly B. L. Diffey Stavros Dimitriadis Thomas M Drake Timothy Donnison Maeva Dupont David W. Eyre Alex Fairman Siobhan Gardiner Javier Gilbert‐Jaramillo Philip Goulder Carl-Philipp Hackstein Sophie Hambleton Muzlifah Haniffa Jenny Haworth Jennifer Holmes Emily C. Horner Anni Jämsén Síle A. Johnson Christopher R. Jones Mwila Kasanyinga Sinéad Kelly Rosemary Kirk Michael L. Knight Allan Lawrie

Extension of the interval between vaccine doses for BNT162b2 mRNA was introduced in United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed study healthcare workers. The first dose induced protection from infection circulating alpha (B.1.1.7) variant over several weeks. In substudy 589 individuals, show that induces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (NAb) responses sustained...

10.1016/j.cell.2021.10.011 article EN cc-by Cell 2021-10-18

The extent to which immune responses natural infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and immunization vaccines protect against variants of concern (VOC) is increasing importance. Accordingly, here we analyse antibodies T cells a recently vaccinated, UK cohort, alongside those recovering from in early 2020. We show that neutralization the VOC compared reference isolate original circulating lineage, B, reduced: more profoundly B.1.351 than for B.1.1.7, or...

10.1038/s41467-021-25167-5 article EN cc-by Nature Communications 2021-08-17
Adrienn Angyal Stéphanie Longet Shona C. Moore Rebecca P. Payne Adam Harding and 95 more Tom Tipton Patpong Rongkard Mohammad Ali Luisa M. Hering Naomi Meardon James E. Austin Rebecca Brown Donal Skelly Natalie Gillson Sue L. Dobson Andrew Cross Gurjinder Sandhar Jonathan A. Kilby Jessica K. Tyerman Alexander R. Nicols Jarmila Stremenova Spegarova Hema Mehta Hailey Hornsby Rachel Whitham Christopher P. Conlon Katie Jeffery Philip Goulder John Frater Christina Dold Matthew Pace Ane Ogbe Helen Brown M. Azim Ansari Emily Adland Anthony Brown Meera Chand Adrian M. Shields Philippa C. Matthews Susan Hopkins Victoria Hall William James Sarah Rowland–Jones Paul Klenerman Susanna Dunachie Alex Richter C.J. Duncan Eleanor Barnes Miles W. Carroll Lance Turtle Thushan I. de Silva Adam Harding Adam Watson Adrian M. Shields Adrienn Angyal Ahmed Alhussni Alex Richter Alexander R. Nicols Alexandra Deeks Alice Webb-Bridges Andrew Cross Ane Ogbe Anni Jämsén Anthony Brown Anu Chawla Christina Dold C.J. Duncan Christopher P. Conlon Donal Skelly Denise O’Donnell Eleanor Barnes Emily Adland Esme Weeks Gurjinder Sandhar Hailey Hornsby Helen Brown Hema Mehta Hibatullah Abuelgasim Huiyuan Xiao James E. Austin Jarmila Stremenova Spegarova Jennifer Holmes Jenny Haworth Jessica K. Tyerman John Frater Jonathan A. Kilby Joseph Cutteridge Katie Jeffery Katy Lillie Lance Turtle Leigh Romaniuk Lucy Denly Luisa M. Hering M. Azim Ansari Matthew Pace Meera Chand Miles W. Carroll Mohammad Ali Mwila Kasanyinga Naomi Meardon Natalie Gillson

10.1016/s2666-5247(21)00275-5 article EN cc-by The Lancet Microbe 2021-11-09

Abstract Identification of protective T cell responses against SARS-CoV-2 requires distinguishing people infected with from those cross-reactive immunity to other coronaviruses. Here we show a range assays that differentially capture immune function characterise responses. Strong ex vivo ELISpot and proliferation multiple antigens (including M, NP ORF3) are found in 168 PCR-confirmed volunteers, but rare 119 uninfected volunteers. Highly exposed seronegative healthcare workers recent...

10.1038/s41467-021-21856-3 article EN cc-by Nature Communications 2021-04-06

B-cell chronic lymphocytic leukaemia (CLL) is associated with immunosuppression and patients are at increased clinical risk following SARS-CoV-2 infection. Covid-19 vaccines offer the potential for protection against severe infection but relatively little known regarding profile of antibody response first or second vaccination. We studied spike-specific responses and/or vaccination in 299 CLL compared healthy donors. 286 underwent extended interval (10-12 week) 154 received BNT162b2 mRNA...

10.1038/s41408-021-00528-x article EN cc-by Blood Cancer Journal 2021-07-30

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and infection outcomes were evaluated in 2,686 patients with varying immune-suppressive disease states after administration of two Coronavirus Disease 2019 (COVID-19) vaccines. Overall, 255 2,204 (12%) failed to develop anti-spike antibodies, an additional 600 (27%) generating low levels (<380 AU ml −1 ). Vaccine failure rates highest ANCA-associated vasculitis on rituximab (21/29, 72%), hemodialysis...

10.1038/s41591-023-02414-4 article EN cc-by Nature Medicine 2023-07-01

Background: Following a single dose of BNT162b2 mRNA vaccine, higher antibody titres are observed following prior SARS-CoV-2 infection than in infection-naive individuals, but T-cell responses less well defined.Methods: We sampled healthcare workers (HCWs) enrolled the UK PITCH study, before and after vaccination. measured spike-specific antibody, quantified by IFNγ ELISpot assay intracellular staining peripheral blood mononuclear cells (PBMC), comparing SARS-CoV-2-naïve individuals to those...

10.2139/ssrn.3812375 article EN SSRN Electronic Journal 2021-01-01

Bangladesh is a South Asian developing country trying to achieve the Sustainable Development Goals (SDG)-3 and objective of Rural Electrification Board (REB) regarding child mortality. Infectious diseases are leading causes mortality, lack exclusive breastfeeding (EBF) among infants aged 0-6 months increases morbidity mortality from various infectious in countries. However, as per existing literature, no study has been conducted yet determine EBF practice effect on Bangladesh. With this...

10.1371/journal.pone.0263890 article EN cc-by PLoS ONE 2022-02-16
Adriana Tomić Donal Skelly Ane Ogbe Daniel O’Connor Matthew Pace and 95 more Emily Adland Frances Alexander Mohammad Ali Kirk Allott M. Azim Ansari Sandra Belij‐Rammerstorfer Sagida Bibi Luke Blackwell Anthony Brown Helen Brown Breeze E. Cavell Elizabeth Clutterbuck Thushan I. de Silva David W. Eyre Sheila Lumley Amy Flaxman James T. Grist Carl-Philipp Hackstein Rachel Halkerston Adam Harding Jennifer Hill Tim James Cecilia Jay Síle A. Johnson Barbara Kronsteiner Yolanda Lie Aline Linder Stephanie Longet Spyridoula Marinou Philippa C. Matthews Jack Mellors Christos J. Petropoulos Patpong Rongkard Cynthia Sedik Laura Silva-Reyes Holly Smith Lisa Stockdale Stephen Taylor Stephen J. Thomas Timothy Tipoe Lance Turtle Vinícius Vieira Terri Wrin Lizzie Stafford Hibatullah Abuelgasim Ahmed Alhussni Carolina V. Arancibia-Cárcamo Martyna Borak Joseph Cutteridge Alexandra Deeks Lucy Denly Stavros Dimitriadis Shayan Fassih Thomas Foord Thomas Fordwoh Jennifer Holmes Bryn Horsington Sven Kerneis David Kim Katy Lillie Jordan Morrow Denise O’Donnell Thomas Ritter Beatrice Simmons A Taylor Sarah Thomas Yolanda Warren Adam Watson Esme Weeks Robert Wilson Rebecca Young C.J. Duncan Shona C. Moore Rebecca P. Payne Alex Richter Sarah Rowland–Jones Alexander J. Mentzer Mark Philip Cassar Tao Dong Anastasia Fries Javier Gilbert‐Jaramillo Ling‐Pei Ho Julian C. Knight Stefan Neubauer Yanchun Peng Nayia Petousi Betty Raman Nick P. Talbot Andrew J. Pollard Teresa Lambe Chris Conlon Katie Jeffery Simon Travis Philip Goulder John Frater

Abstract The trajectories of acquired immunity to severe acute respiratory syndrome coronavirus 2 infection are not fully understood. We present a detailed longitudinal cohort study UK healthcare workers prior vaccination, presenting April-June 2020 with asymptomatic or symptomatic infection. Here we show highly variable range responses, some which (T cell interferon-gamma ELISpot, N-specific antibody) wane over time, while others (spike-specific antibody, B memory ELISpot) stable. use...

10.1038/s41467-022-28898-1 article EN cc-by Nature Communications 2022-03-10

Abstract Background People with human immunodeficiency virus (HIV) on antiretroviral therapy (ART) good CD4 T-cell counts make effective immune responses following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are few data longer term and the impact of a booster dose. Methods Adults HIV were enrolled into single arm open label study. Two doses ChAdOx1 nCoV-19 followed 12 months later by third heterologous vaccine Participants had undetectable...

10.1093/cid/ciac796 article EN cc-by Clinical Infectious Diseases 2022-10-05

<title>Abstract</title> Older adults are particularly vulnerable to infectious diseases, and vaccines often less effective in this population due immunosenescence, which is characterized by diminished B T memory responses. Autophagy believed underlie many facets of cellular aging, including immunosenescence. It crucial for maintaining cell functions but declines with age, along the endogenous metabolite spermidine that helps maintain autophagy levels. We conducted a double-blind, randomized,...

10.21203/rs.3.rs-5686388/v1 preprint EN Research Square (Research Square) 2025-04-02

<title>Abstract</title> COVID-19 vaccines were updated to address immune escape from variants of concern (VOC). We explored the impact ancestral/BA.1 bivalent mRNA booster vaccination (Autumn 2022) on peripheral and nasal antibody T-cell responses SARS-CoV-2 in 133 healthcare workers, building previous longitudinal studies. demonstrate that maintenance up eighteen months following third vaccine is at least partially driven by intercurrent infection. Boosting with increases breadth...

10.21203/rs.3.rs-6377378/v1 preprint EN Research Square (Research Square) 2025-04-11

The rapid proliferation of germinal center (GC) B cells requires metabolic reprogramming to meet energy demands, yet these processes are poorly understood. By integrating metabolomic and transcriptomic profiling GC cells, we identified that asparagine (Asn) metabolism was highly up-regulated essential for cell function. Asparagine synthetase (ASNS) after activation through the integrated stress response sensor GCN2. Conditional deletion

10.1126/sciimmunol.adl4613 article EN Science Immunology 2024-12-13

Defining correlates of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine breakthrough infection informs policy for booster doses and future designs. Existing studies demonstrate humoral protection, but the role T cells in is still unclear. In this study, we explore antibody cell immune responses associated with Delta variant a well-characterized cohort UK Healthcare Workers (HCWs). We evidence to support CD4+ CD8+ as well antibodies infection. addition,...

10.1128/mbio.01212-23 article EN cc-by mBio 2023-09-01

Framing analysis is predominantly qualitative and quantitative, examining a small dataset with manual coding. Easy access to digital data in the last two decades prompts scholars both computation social sciences utilize various computational methods explore frames large-scale datasets. The growing scholarship, however, lacks comprehensive understanding resources of framing methods. Aiming address gap, this article surveys existing approaches puts them together. research expected help...

10.18653/v1/2022.emnlp-main.633 article EN cc-by Proceedings of the 2021 Conference on Empirical Methods in Natural Language Processing 2022-01-01

Abstract Objective: Obesity and type 2 diabetes (DM) are risk factors for severe coronavirus disease 2019 (COVID-19) outcomes, which disproportionately affect South Asian populations. This study aims to investigate the humoral cellular immune responses SARS-CoV-2 in adult COVID-19 survivors with overweight/obesity (Ov/Ob, BMI ≥ 23 kg/m2) DM Bangladesh. Methods: In this cross-sectional study, SARS-CoV-2-specific antibody T-cell were investigated 63 healthy 75 PCR-confirmed recovered...

10.1093/cei/uxae030 article EN cc-by Clinical & Experimental Immunology 2024-04-20

Abstract A major issue in identification of protective T cell responses against SARS-CoV-2 lies distinguishing people infected with from those cross-reactive immunity generated by exposure to other coronaviruses. We characterised immune 168 PCR-confirmed subjects and 118 seronegative without known using a range assays that differentially capture function. Strong ex vivo ELISpot proliferation multiple antigens (including M, NP ORF3) were found who had been but rare pre-pandemic unexposed...

10.1101/2020.09.28.20202929 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-09-29

Objective: To find out relative frequency and type of malignancy in solitary thyroid nodule (STN).Methods: This cross sectional study done the Department Otolaryngology Head &amp; Neck Surgery, Dhaka Medical College Hospital (DMCH), Bangabandhu Sheikh Mujib University (BSMMU), during period July 2008 to June 2009. For this study, 118 patients who were admitted a case for operation. Diagnosed by detailed history, clinical examination, investigations, analyzed data presented various tables,...

10.3329/bjo.v18i1.10407 article EN cc-by Bangladesh Journal of Otorhinolaryngology 2012-04-20

ABSTRACT T cell correlates of protection against SARS-CoV-2 infection after vaccination (‘vaccine breakthrough’) are incompletely defined, especially the specific contributions CD4+ and CD8+ cells. We studied 279 volunteers in Protective Immunity from Cells Healthcare Workers (PITCH) UK study, including 32 cases (with positive testing two vaccine doses during Delta-dominant era) 247 controls (no test nor anti-nucleocapsid seroconversion this period). 28 days second vaccination, before all...

10.1101/2023.02.16.23285748 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2023-02-17
Coming Soon ...